The Data Controller responsible for processing the data compiled over this website is Pensa Pharma AB (from hereinafter referred to as "Pensa Pharma"), with address at Birger Jarlsgatan 22, SE-114 34 Stockholm, telephone no. +46(0)8 440 37 30 and contact e-mail address email@example.com
It is essential for Pensa Pharma to maintain the privacy and security of our users' personal data. We do not require any type of registration, thus enabling you to visit this website without having to identify yourself. However, providing your personal data could be necessary for some services and information.
We inform you that the personal data you provide to us through this website, or that we compile, will be processed for the following purposes (or some of them, depending on the purpose):
i. To attend the information requests and/or queries made by users. The data processed for this purpose will be kept by Pensa Pharma until the statutory period of limitations provided by law has expired, after having resolved your request for information and/or consultation. The legal basis to carry out this data processing is your consent.
ii. To manage and maintain the commercial relationship with Pensa Pharma. The data processed with this purpose will be kept by Pensa Pharma while the commercial relationship between the parties is maintained and, once finalised, until the statutory period of limitations provided by law has expired. The legal basis to carry out this data processing is the performance of a contract to which the data subject is party (or in order to take steps at the request of the data subject prior to entering into a contract) or the legitimate interest pursued by Pensa Pharma, depending on the case.
iii. To attend, analyze and manage any information containing adverse reaction reported by users through this website. Such data will be kept by Pensa Pharma during the legally established periods. The legal basis to carry out this data processing is compliance with legal obligations in terms of pharmacovigilance.
The data will be processed with the appropriate degree of protection, adopting proper technical and organizational measures to avoid their alteration, accidental loss, unauthorized dissemination or access, and any other improper processing. The nature of the data processed, the risk, as well as the technology advances and implementation costs, among other aspects, are taken into consideration to apply these measures.
Users can exercise their rights of access, rectification, erasure, restriction of processing, data portability and right to object. Likewise, when processing users' data whose legitimation is based on the consent given by said users, the latter are entitled to withdraw their consent at any time, without this affecting the legality of the processing based on the consent given prior to its withdrawal.
To exercise these rights, users may send their written request to Pensa Pharma AB, Birger Jarlsgatan 22, SE-114 34 Stockholm, Sweden or an e-mail to be following address: firstname.lastname@example.org
In any case, users are entitled to file a complaint before the relevant supervisory authority, if deemed appropriate.